Similar articles for PMID: 9809930

Year	Number of Results
1958	1
1973	1
1979	1
1982	2
1983	3
1984	3
1985	5
1986	4
1987	5
1988	4
1989	11
1990	5
1991	2
1992	2
1993	6
1994	4
1995	8
1996	15
1997	16
1998	16
1999	10
2000	11
2001	21
2002	10
2003	11
2004	12
2005	10
2006	5
2007	14
2008	13
2009	12
2010	8
2011	11
2012	8
2013	7
2014	7
2015	4
2016	3
2017	3
2018	5
2019	4
2020	7
2021	1
2023	1
2024	0

1

Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.

Pepine CJ, Handberg-Thurmond E, Marks RG, Conlon M, Cooper-DeHoff R, Volkers P, Zellig P. Pepine CJ, et al. J Am Coll Cardiol. 1998 Nov;32(5):1228-37. doi: 10.1016/s0735-1097(98)00423-9. J Am Coll Cardiol. 1998. PMID: 9809930 Free article. Clinical Trial.

2

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators. Pepine CJ, et al. JAMA. 2003 Dec 3;290(21):2805-16. doi: 10.1001/jama.290.21.2805. JAMA. 2003. PMID: 14657064 Clinical Trial.

3

Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).

Sava RI, Chen YE, Smith SM, Gong Y, Cooper-DeHoff RM, Keeley EC, Pepine CJ, Handberg EM. Sava RI, et al. J Womens Health (Larchmt). 2020 Feb;29(2):158-166. doi: 10.1089/jwh.2018.7235. Epub 2019 Aug 12. J Womens Health (Larchmt). 2020. PMID: 31403360

4

Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.

Bakris GL, Cooper-Dehoff RM, Zhou Q, Kupfer S, Champion A, Pepine CJ; INVEST Investigators. Bakris GL, et al. Am J Cardiovasc Drugs. 2007;7 Suppl 1:25-9. doi: 10.2165/00129784-200707001-00004. Am J Cardiovasc Drugs. 2007. PMID: 19845074 Clinical Trial.

5

Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.

Bangalore S, Messerli FH, Cohen JD, Bacher PH, Sleight P, Mancia G, Kowey P, Zhou Q, Champion A, Pepine CJ; INVEST Investigators. Bangalore S, et al. Am Heart J. 2008 Aug;156(2):241-7. doi: 10.1016/j.ahj.2008.02.023. Am Heart J. 2008. PMID: 18657652 Clinical Trial.

6

Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).

Zineh I, Cooper-Dehoff RM, Wessel TR, Arant CB, Sleight P, Geiser EA, Pepine CJ. Zineh I, et al. Clin Cardiol. 2005 Jul;28(7):321-8. doi: 10.1002/clc.4960280704. Clin Cardiol. 2005. PMID: 16075824 Free PMC article. Clinical Trial.

7

Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.

Bakris GL, Gaxiola E, Messerli FH, Mancia G, Erdine S, Cooper-DeHoff R, Pepine CJ; INVEST Investigators. Bakris GL, et al. Hypertension. 2004 Nov;44(5):637-42. doi: 10.1161/01.HYP.0000143851.23721.26. Epub 2004 Sep 20. Hypertension. 2004. PMID: 15381674

8

INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.

Cooper-DeHoff RM, Handberg EM, Mancia G, Zhou Q, Champion A, Legler UF, Pepine CJ. Cooper-DeHoff RM, et al. Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1329-40. doi: 10.1586/erc.09.102. Expert Rev Cardiovasc Ther. 2009. PMID: 19900016 Free PMC article.

9

Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).

Cooper-DeHoff RM, Aranda JM Jr, Gaxiola E, Cangiano JL, Garcia-Barreto D, Conti CR, Hewkin A, Pepine CJ; INVEST Investigators. Cooper-DeHoff RM, et al. Am Heart J. 2006 May;151(5):1072-9. doi: 10.1016/j.ahj.2005.05.024. Am Heart J. 2006. PMID: 16644338

10

A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).

Ried LD, Tueth MJ, Handberg E, Kupfer S, Pepine CJ; INVEST Study Group. Ried LD, et al. Psychosom Med. 2005 May-Jun;67(3):398-406. doi: 10.1097/01.psy.0000160468.69451.7f. Psychosom Med. 2005. PMID: 15911902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

299 results

Results by year